ERIE Form 4: Director adds 84.246 share credits; holds 20,079.243

Erie Indemnity (ERIE) director reported routine activity tied to the Outside Directors' plans.

Rhea-AI Filing Summary

Erie Indemnity (ERIE) director reported routine activity tied to the Outside Directors' plans. On 10/21/2025, the reporting person acquired 84.246 Directors' Deferred Compensation Share Credits (transaction code J) under dividend reinvestment at a price of $325.89 per credit.

Following the transaction, the director beneficially owned 20,079.243 derivative share credits directly. Separately, 10,000 Class A common shares were beneficially owned indirectly via the J. Ralph Borneman, Jr. Revocable Trust DTD 02/16/2015. These share credits represent the right to receive an equivalent number of Class A shares when board service ends and have no exercisable or expiration dates.

Insider Trade Summary

Other: 84.246 shares

Other 2 txns

Insider BORNEMAN J RALPH JR

Role Director

Type	Security	Shares	Price	Value
Other	Directors' Deferred Compensation Share Credits	84.246	$325.89	$27K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Directors' Deferred Compensation Share Credits — 20,079.243 contracts (Direct); Class A Common Stock — 10,000 shares (Indirect, J. Ralph Borneman, Jr. TTEE J. Ralph Borneman, Jr. Revocable Trust DTD 02/16/2015)

Footnotes (3)

1. F1. Conversion price is not applicable to shares granted under the Outside Directors' Deferred Compensation Plan.
2. F2. Acquired under dividend reinvestment for Directors' Deferred Compensation Plan.
3. F3. The shares subject to this reporting are Share Credits which are periodically credited to the accounts of certain Directors of Erie Indemnity Company pursuant to its Outside Directors' Stock Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual's service as a Director of the Company ends. There are no exercisable or expiration dates for these securities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ERIE (ERIE) disclose in this Form 4 filing?

A director acquired 84.246 Directors' Deferred Compensation Share Credits on 10/21/2025 via dividend reinvestment (code J) at $325.89.

How many derivative share credits does the ERIE director hold after the transaction?

The filing shows 20,079.243 derivative share credits beneficially owned directly following the reported transaction.

What is the price associated with the share credits in the ERIE Form 4?

The reported price for the Directors' Deferred Compensation Share Credits is $325.89.

What do ERIE Directors' Deferred Compensation Share Credits represent?

They represent the right to receive an equivalent number of Class A common shares when the director’s service ends; they have no exercisable or expiration dates.

Does the ERIE director report any indirect ownership of Class A shares?

Yes. The filing lists 10,000 Class A shares held indirectly via the J. Ralph Borneman, Jr. Revocable Trust DTD 02/16/2015.

What is the transaction code used and what does it signify?

Transaction code J is reported, with the filing noting acquisition under dividend reinvestment for the Directors' Deferred Compensation Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/22/2025 - 01:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BORNEMAN J RALPH JR

(Last) (First) (Middle)

17 E. PHILADELPHIA AVENUE

PO BOX 584

(Street)

BOYERTOWN PA 19512

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ERIE INDEMNITY CO [ ERIE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock								10,000	I	J. Ralph Borneman, Jr. TTEE J. Ralph Borneman, Jr. Revocable Trust DTD 02/16/2015

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Directors' Deferred Compensation Share Credits	$0(1)	10/21/2025		J(2)		84.246		(3)	(3)	Class A Common Stock	84.246	$325.89	20,079.243	D

Explanation of Responses:

1. Conversion price is not applicable to shares granted under the Outside Directors' Deferred Compensation Plan.

2. Acquired under dividend reinvestment for Directors' Deferred Compensation Plan.

3. The shares subject to this reporting are Share Credits which are periodically credited to the accounts of certain Directors of Erie Indemnity Company pursuant to its Outside Directors' Stock Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual's service as a Director of the Company ends. There are no exercisable or expiration dates for these securities.

Remarks:

	Rebecca A. Buona, Power of Attorney	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.